OPRELVEKIN
UNII HM5641GA6F

Substance Identification & Data

This profile provides standardized clinical and technical data for Oprelvekin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HM5641GA6F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 145941-26-0 and the RxNorm Concept ID (RxCUI) 139994. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
HM5641GA6F
CAS Registry Number
145941-26-0
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
OPRELVEKIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
7558
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
FF-30
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oprelvekin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OPRELVEKIN

Common Names & Synonyms

2-178-INTERLEUKIN 11 (HUMAN CLONE PXM/IL-11)
INTERLEUKIN-11 (2-178)
OPRELVEKIN [INN]
OPRELVEKIN [JAN]
OPRELVEKIN [MART.]
OPRELVEKIN [MI]
OPRELVEKIN [PURPLE BOOK CDER]
OPRELVEKIN [USAN]
OPRELVEKIN [VANDF]
OPRELVEKIN [WHO-DD]

Brand / Trade Names

NEUMEGA